Fortune Oil and Gas, Inc. announces 1 for 10 reverse split along with a name change to Manzo Pharmaceuticals is now effective

MILFORD, Pa., Sept. 17, 2014 /PRNewswire/ -- Fortune Oil and Gas, Inc. (OTCPink:FOGC), today announced that it has officially changed its name to Manzo Pharmaceuticals, Inc. with the symbol (OTCPink : FOGCD). FINRA approved the change to take effect today, September 17, 2014. Also taking effect today is a ten for 1 reverse split.

The approval is a pivotal event in the company's progress according to CEO, Kenneth Manzo. Mr. Manzo explained, "We could not proceed with the plan and still have any level of success without these changes approved. Making major advancements in the treatment of medical conditions and illnesses, we had to hold off with public announcements because the company name would not have made sense, and would have taken away from branding and marketing efforts that are so critical at these stages of the company's growth. I did originally say there would be no unnecessary dilution or reverse splits, and even though I did mean it wholeheartedly, it became clear that a reverse split was going to be absolutely necessary and unavoidable if we were to become successful. So, with the shareholder in mind, I did as small a reverse-split as I could, giving the shareholder one share post-split for every ten shares they held previously. A factor of ten will allow us to have some control over the float, and still offer shareholders a minimal price increase which hedges against a huge drop as we move forward." He went on to further explain, " I know it is not a popular decision, but with the advancements we have in the queue, the incredible life-changing probiotics currently undergoing testing, and the very minimal need to do future issuances, there is no doubt in my mind that the company now has a real chance for success and a tremendous up-side moving forward."

According to the FINRA notification, the name change and reverse split take effect today, September 17, 2014, with the Symbol changing to FOGCD temporarily, and then to MNZO on October 14^th. Now that the company is operating as Manzo Pharmaceuticals, Inc. a strategy for releasing current development to the public is being put together and shareholders should expect many developments in the very near future. On top of the list is the company's patent pending probiotic for people who suffer from lactose intolerance but many other products, partnerships, and developments have been being worked on over the past two months. The new technology that enables the probiotic to curb lactose intolerance symptoms has many applications, putting Manzo Pharmaceuticals in the position of developing and licensing that technology creating solutions that could put the company on the map.

About Manzo Pharmaceuticals, Inc.

Manzo Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development, and testing of patented and non-patented solutions and remedies. Most notably is a patented solution for lactose Intolerance, and a natural remedy for colic in babies. For more information follow the company on twitter at @manzopharma, and visit www.manzopharma.com.

DISCLAIMER:

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

SOURCE Fortune Oil and Gas, Inc.